Evome Medical Technologies Inc. (LNDZF)
OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 8.22M |
| Enterprise Value | 21.71M |
| Trailing P/E | 20.45 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.20 |
| Price/Book (mrq) | 5.70 |
| Enterprise Value/Revenue | 0.51 |
| Enterprise Value/EBITDA | -2.55 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.92 |
| 52-Week Change 3 | -37.89% |
| S&P500 52-Week Change 3 | 26.33% |
| 52 Week High 3 | 0.2100 |
| 52 Week Low 3 | 0.0111 |
| 50-Day Moving Average 3 | 0.1343 |
| 200-Day Moving Average 3 | 0.1655 |
Share Statistics
| Avg Vol (3 month) 3 | 1.38k |
| Avg Vol (10 day) 3 | N/A |
| Shares Outstanding 5 | 59.81M |
| Implied Shares Outstanding 6 | 91.83M |
| Float 8 | 54.21M |
| % Held by Insiders 1 | 15.73% |
| % Held by Institutions 1 | 9.49% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | � |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | Dec 14, 2020 |
| Ex-Dividend Date 4 | May 24, 2017 |
| Last Split Factor 2 | 0.737:1 |
| Last Split Date 3 | Dec 15, 2020 |
Financial Highlights
Currency in CAD.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Jun 30, 2024 |
Profitability
| Profit Margin | -35.36% |
| Operating Margin (ttm) | -17.50% |
Management Effectiveness
| Return on Assets (ttm) | -35.78% |
| Return on Equity (ttm) | -289.79% |
Income Statement
| Revenue (ttm) | 54.86M |
| Revenue Per Share (ttm) | 0.65 |
| Quarterly Revenue Growth (yoy) | -38.00% |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -19.39M |
| Diluted EPS (ttm) | -0.1800 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.07M |
| Total Cash Per Share (mrq) | 0.01 |
| Total Debt (mrq) | 19.39M |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.55 |
| Book Value Per Share (mrq) | -0.03 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.42M |
| Levered Free Cash Flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.